Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and anticancer evaluation of novel quinoline derivatives of ursolic acid with hydrazide, oxadiazole, and thiadiazole moieties as potent MEK inhibitors
Xiaoyan Jin, Hao Chen, Dong‐Dong Li, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2019) Vol. 34, Iss. 1, pp. 955-972
Open Access | Times Cited: 59

Showing 26-50 of 59 citing articles:

Report on Recently (2017–20) Designed Quinoline‐Based Human Cancer Cell Growth Inhibitors
Atukuri Dorababu
ChemistrySelect (2020) Vol. 5, Iss. 44, pp. 13902-13915
Closed Access | Times Cited: 26
Antibacterial activity and action mechanism of microencapsulated dodecyl gallate with methyl-β-cyclodextrin
Junxin Zhao, Ting Peng, Shibo Liang, et al.
Food Control (2019) Vol. 109, pp. 106953-106953
Closed Access | Times Cited: 25
Natural products and skeletal muscle health
Zhihao Qu, Shiyu Zhou, Penghui Li, et al.
The Journal of Nutritional Biochemistry (2021) Vol. 93, pp. 108619-108619
Closed Access | Times Cited: 21
ZNF143 Suppresses Cell Apoptosis and Promotes Proliferation in Gastric Cancer via ROS/p53 Axis
Yi Zhang, Qing Li, Wei Song, et al.
Disease Markers (2020) Vol. 2020, pp. 1-15
Open Access | Times Cited: 21
Synthesis and antimalarial and anticancer evaluation of 7‐chlorquinoline‐4‐thiazoleacetic derivatives containing aryl hydrazide moieties
Hégira Ramírez, Esteban Fernández-Moreira, Juan Rodrígues, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 7
Closed Access | Times Cited: 16
Recent developments in mitogen activated protein kinase inhibitors as potential anticancer agents
Vikram Jeet Singh, Bharti Sharma, Pooja A. Chawla
Bioorganic Chemistry (2021) Vol. 114, pp. 105161-105161
Closed Access | Times Cited: 15
Soloxolone Methyl Reduces the Stimulatory Effect of Leptin on the Aggressive Phenotype of Murine Neuro2a Neuroblastoma Cells via the MAPK/ERK1/2 Pathway
Kirill V. Odarenko, Oksana V. Salomatina, Ivan V. Chernikov, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1369-1369
Open Access | Times Cited: 5
Anti-proliferative activity of nitroquinolone fused acylhydrazones as non-small cell human lung cancer agents
Vandana Nandakumar, Sundarasamy Amsaveni, Kaviyarasu Adhigaman, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 7, pp. 1331-1343
Closed Access | Times Cited: 4
Novel 3′-Substituted-1′,2′,4′-Oxadiazole Derivatives of 18βH-Glycyrrhetinic Acid and Their O-Acylated Amidoximes: Synthesis and Evaluation of Antitumor and Anti-Inflammatory Potential In Vitro and In Vivo
Andrey V. Markov, Aleksandra V. Sen’kova, Irina I. Popadyuk, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3511-3511
Open Access | Times Cited: 13
Quinoline-pyrimidine hybrid compounds from 3-acetyl-4-hydroxy-1-methylquinolin-2(1H)-one: Study on synthesis, cytotoxicity, ADMET and molecular docking
Duong Ngoc Toan, Nguyễn Đình Thành, Mai Xuan Truong, et al.
Arabian Journal of Chemistry (2020) Vol. 13, Iss. 11, pp. 7860-7874
Open Access | Times Cited: 13
Discovery of N-(1,3,4-thiadiazol-2-yl)benzamide derivatives containing a 6,7-methoxyquinoline structure as novel EGFR/HER-2 dual-target inhibitors against cancer growth and angiogenesis
Xinyang Li, De-pu Wang, Shuai Li, et al.
Bioorganic Chemistry (2021) Vol. 119, pp. 105469-105469
Closed Access | Times Cited: 12
Synthesis, Biocidal and Antibiofilm Activities of New Isatin–Quinoline Conjugates against Multidrug-Resistant Bacterial Pathogens along with Their In Silico Screening
Elshaymaa I. Elmongy, Abdullah Akhtar Ahmed, Ibrahim El Tantawy El Sayed, et al.
Antibiotics (2022) Vol. 11, Iss. 11, pp. 1507-1507
Open Access | Times Cited: 7
An Update on Chemical Classes Targeting ERK1/2 for the Management of Cancer
Shelly Pathania, Ravindra K. Rawal
Future Medicinal Chemistry (2020) Vol. 12, Iss. 7, pp. 593-611
Closed Access | Times Cited: 10
Synthesis and applications of some new nitrogen-containing heterocyclic azo-disperse dyes bearing quinoline chromophore
Khalid Mahmoud Hassan, Shaban Abdel Sattar ElKhabiery, G.M. Elhaddad, et al.
Journal of the Iranian Chemical Society (2021) Vol. 19, Iss. 1, pp. 147-158
Closed Access | Times Cited: 9
Green Synthesis, Experimental and Theoretical Studies to Discover Novel Binders of Exosomal Tetraspanin CD81 Protein
Krishnan Anand, Faez Iqbal Khan, Thishana Singh, et al.
ACS Omega (2020) Vol. 5, Iss. 29, pp. 17973-17982
Open Access | Times Cited: 9
Cyclin-dependent kinase 4/6 inhibitors for cancer therapy: a patent review (2015 – 2019)
Pengfei Wang, Han‐Yue Qiu, Yun He, et al.
Expert Opinion on Therapeutic Patents (2020) Vol. 30, Iss. 10, pp. 795-805
Closed Access | Times Cited: 8
Recent Updates on Synthesis, Biological Activity, and Structure-activity Relationship of 1,3,4-Oxadiazole-quinoline Hybrids: A Review
Abhishek Shankar Sharma, Salahuddin Salahuddin, Avijit Mazumder, et al.
Current Organic Synthesis (2022) Vol. 20, Iss. 7, pp. 758-787
Closed Access | Times Cited: 5
Combined RNAi of CTTN and FGF2 Modulates Cell Migration, Invasion and G1/S Transition of Hepatocellular Carcinoma through Ras/ERK Signaling Pathway
Jiaming Zhou, Jiaxuan Liu, Tiejun Li, et al.
Current Cancer Drug Targets (2024) Vol. 24, Iss. 8, pp. 791-803
Closed Access
A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases
Nilam Bhusare, MAUSHMI KUMAR
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 5, pp. 849-875
Open Access
Synthesis, Antioxidant, and Anticancer Studies of New 1,3,4‐Oxadiazole Derivatives Linked to Benzoquinoline
Ahmed A. Fadda, Eslam R. El‐Sawy, T. A. Zidan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 28
Closed Access
Thiazolidinedione-Conjugated Lupeol Derivatives as Potent Anticancer Agents Through a Mitochondria-Mediated Apoptotic Pathway
Siqi Deng, Yinxu Zhao, Xiaoshan Guo, et al.
Molecules (2024) Vol. 29, Iss. 20, pp. 4957-4957
Open Access
Astrocytes, a Promising Opportunity to Control the Progress of Parkinson’s Disease
Alberto Sánchez, Ingrid Moráles, Clara Rodriguez‐Sabate, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1341-1341
Open Access | Times Cited: 5
Synthesis of new 3‐(hydroxymethyl)‐2‐phenyl‐2,3 dihydroquinolinone and in‐silico evaluation of COVID‐19 main protease inhibitor
Nepolraj Amaladoss, V. I. Shupeniuk, Manisekar Sathiyaseelan, et al.
Vietnam Journal of Chemistry (2021) Vol. 59, Iss. 4, pp. 511-521
Open Access | Times Cited: 4
Synthesis, Molecular Docking Studies and Cytotoxic Screening of Novel 2-Substituted Benzimidazole Derivatives
Rani S. Kankate, Sunita N Surse, Pooja Abhang, et al.
International Journal of Membrane Science and Technology (2023) Vol. 10, Iss. 3, pp. 2568-2579
Open Access | Times Cited: 1
A simple method for the rapid synthesis of 2-amino-7,7-dimethyl-5-oxo-1,4-diaryl-hexahydroquinoline-3-carboxamide derivatives
Fahimeh Sadat Hosseini, Mohammad Bayat
Journal of the Iranian Chemical Society (2020) Vol. 17, Iss. 9, pp. 2267-2274
Closed Access | Times Cited: 3

Scroll to top